Oral fluorouracil vs vinorelbine plus cisplatin as adjuvant chemotherapy for stage II-IIIA non-small cell lung cancer: Propensity score-matched and instrumental variable analyses.
Hirokazu UrushiyamaYoshimune HiratsukaHideo YasunagaNobuaki MichihataHiroki MatsuiWakae HasegawaHideyuki TakeshimaYukiyo SakamotoYoshihisa HiraishiAkihisa MitaniKiyohide FushimiTakahide NagaseYasuhiro YamauchiPublished in: Cancer medicine (2018)
On a large nationwide cohort, adjuvant chemotherapy with oral fluorouracil prolonged recurrence-free survival in patients with postoperative stage II-IIIA NSCLC, compared with VNR/CDDP. Oral fluorouracil may thus be a useful alternative to VNR/CDDP for the adjuvant treatment of these patients.